
Lower bleeding rates but no increase in risk of death, MI, or stroke topped results reported from the TWIGHLIGHT study which compared ticagrelor monotherapy at 3 months post-PCI vs ticarelor plus aspirin.

Lower bleeding rates but no increase in risk of death, MI, or stroke topped results reported from the TWIGHLIGHT study which compared ticagrelor monotherapy at 3 months post-PCI vs ticarelor plus aspirin.

Veterans who suffer from mental illness were found to be at an increased risk for major cardiovascular disease outcomes in a new study.

Cases of infective endocarditis are on the rise and a new study suggests the opioid epidemic could be to blame.

A recent study suggests blood pressure patterns later in life may be linked to dementia risk. Which patient cohort is at an increased risk?

What's your caffeine IQ? Test your knowledge on the latest caffeine research from its effect on cardiovascular disease to liver cancer with this brief quiz.

A large Swedish cohort study suggests that when it come to risk of atrial fibrillation, there are differences in the way women and men respond to endurance training.

Heavy smokers who quit remain at significantly increased CVD risk for up to 10 years or more, according to new research. Results suggest that current risk estimators may need revision.

Caffeine moderation moderates cardiovascular risk, caffeine is not what is keeping you up at night, and 4 more recent studies on caffeine intake.

Red meat is known to be linked to various health risks, but what other dangers could beef intake pose? Brush up on recent research with these 5 questions.

Americans still don't meet guideline-recommended physical activity levels even while sedentary behavior increases, according to a new NHANES analysis.

Summer brings sunburn, chemical exposure, allergies, and heat-related ills. Catch up on recent research on some of the unpleasant syndromes of summer.

Study: "Ideal" adherence to healhty habits (eg, weight control, no smoking, average A1c) may reduce risk of heart failure by >50% vs "inadequate" adherence.

US consumption of red meat remains twice the global average. New research highlights the consequences of that intake in terms of all-cause mortality.

A new study finds that higher caffeine intake may decrease the risk of patients developing new onset atrial fibrillation.

Saturated fat and cholesterol from red meat have long been known to be bad for heart health, but recent research sheds light on a possible new culprit.

In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended?

The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.

ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis.

ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.

Patients know that regular exercise is important but often need guidance on what's best. A pulmonologist advises on how to asses individual needs, utilize guidelines, and create a plan.

A personal EKG monitor, an app that wirelessly connects to a smart thermometer, and 3 more FDA-cleared apps for primary care.

Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.

Eighty percent of all cardiovascular events are preventable. The ACC/AHA 2019 guidelines are a single source of best practices to help achieve that goal. Review them here, at-a-glance.

From a mobile EKG monitor to a digital urinalysis app, these medical "devices" are changing the way healthcare is delivered.

Dapagliflozin, icosapent ethyl, and bempedoic acid were found to reduce clinical or surrogate CV endpoints in studies presented at ACC.19, March 16-18, in New Orleans, LA.